AN2 Therapeutics, Inc.

NASDAQ:ANTX

Biotechnology

Healthcare
$5.22 +0.82%

+$0.04 today

Market cap
$198.07M
Beta
-0.98
P/E (TTM)
-4.9
EPS (TTM)
-$1.01
52W Low $1.00High $6.91

Volume 0.79M

Average 0.29M

Balance Sheet

Inspect the capital base behind the business.

Assets

$61.95M

FY 2025 · Annual

-32.7% YoY

Liabilities

$8.89M

FY 2025 · Annual

-13.2% YoY

Equity

$53.06M

FY 2025 · Annual

-35.2% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents12.1M27.22M15.65M21.35M19.94M
Short-term Investments46.46M68.84M91.65M62.27M38.06M
Net Receivables001.4M300K900K
Inventory00000
Other Current Assets1.55M2.56M3.21M2.34M1.04M
Total Current Assets60.11M98.62M110.51M86.26M59.94M
Property, Plant & Equipment (Net)053K000
Goodwill00000
Intangible Assets00000
Long-term Investments3.49M3.22M27.19M5.02M2.01M
Tax Assets00000
Other Non-current Assets1.72M667K1.04M804K0
Total Non-current Assets5.21M3.94M28.24M5.83M2.01M
Total Assets65.32M102.56M138.74M92.09M61.95M
Account Payables1.06M2.12M2.68M3.32M3.02M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities330K6K4.69M2.47M3.28M
Total Current Liabilities3.4M7.19M14.04M10.24M8.72M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities13K2K00170K
Total Non-current Liabilities13K2K00170K
Total Liabilities3.41M7.19M14.04M10.24M8.89M
Common Stock00000
Retained Earnings(47.38M)(89.72M)(154.46M)(205.78M)(240.95M)
Accumulated OCI(27K)(374K)275K31K57K
Other Stockholders Equity00000
Minority Interest00000
Total Equity61.91M95.37M124.7M81.85M53.06M
Total Debt053K000
Net Debt(12.1M)(27.17M)(15.65M)(21.35M)(19.94M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$53.5M
Short-term Investments$31.8M
Receivables$300.0K
Other Current$1.9M
Total Current Assets$87.5M
Total Assets$87.5M

Analysis

Selected assets total $87.5M for Latest. The largest visible component is Cash & Equivalents at $53.5M, about 61.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
SC 13G/ASC 13G/A filingNov 13, 2026
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 9, 2026
4Statement of changes in beneficial ownershipNov 6, 2026

How much cash does ANTX have?

AN2 Therapeutics, Inc. (ANTX) reported $19.94M in cash and equivalents in fiscal 2025.

How much debt does ANTX carry?

AN2 Therapeutics, Inc. (ANTX) reported $0.00 of total debt, with net debt of -$19.94M.